218 related articles for article (PubMed ID: 19653113)
1. The factors that affect plasma homocysteine levels, pulse wave velocity and their relationship with cardiovascular disease indicators in peritoneal dialysis patients.
Ertek S; Torun AN; Ates K
Int Urol Nephrol; 2010 Mar; 42(1):211-8. PubMed ID: 19653113
[TBL] [Abstract][Full Text] [Related]
2. What is the meaning of homocysteine in patients on dialysis?
Silva de Almeida CC; Guerra DC; Vannucchi MT; Geleilete TJ; Vannucchi H; Chiarello PG
J Ren Nutr; 2011 Sep; 21(5):394-400. PubMed ID: 21439851
[TBL] [Abstract][Full Text] [Related]
3. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.
Bostom AG; Shemin D; Lapane KL; Nadeau MR; Sutherland P; Chan J; Rozen R; Yoburn D; Jacques PF; Selhub J; Rosenberg IH
Atherosclerosis; 1996 Jun; 123(1-2):193-202. PubMed ID: 8782850
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinemia in chronic renal failure patients: relation to tissue factor and platelet aggregation.
Cetin O; Bekpinar S; Unlucerci Y; Turkmen A; Bayram C; Ulutin T
Clin Nephrol; 2006 Feb; 65(2):97-102. PubMed ID: 16509458
[TBL] [Abstract][Full Text] [Related]
5. Effective homocysteine-lowering vitamin B treatment in peritoneal dialysis patients.
Righetti M; Tommasi A; Lagona C; La Rosa L; Uccellini M; Sessa A
Perit Dial Int; 2004; 24(4):373-7. PubMed ID: 15335152
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients.
Ohkuma T; Minagawa T; Takada N; Ohno M; Oda H; Ohashi H
Am J Kidney Dis; 2003 Aug; 42(2):355-61. PubMed ID: 12900819
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with increased plasma homocysteine in patients using an amino acid peritoneal dialysis fluid.
Yang SY; Huang JW; Shih KY; Hsu SP; Chu PL; Chu TS; Wu KD
Nephrol Dial Transplant; 2005 Jan; 20(1):161-6. PubMed ID: 15572386
[TBL] [Abstract][Full Text] [Related]
8. [Characteristics of hyperhomocysteinemia in dialysis patients].
Lovcić V; Kes P; Reiner Z
Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia in children on renal replacement therapy.
Feinstein S; Sela BA; Drukker A; Becker-Cohen R; Raveh D; Gavendo S; Frishberg Y
Pediatr Nephrol; 2002 Jul; 17(7):515-9. PubMed ID: 12172765
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine, vitamin B12, and serum and erythrocyte folate in peritoneal dialysis and hemodialysis patients.
De Vecchi AF; Bamonti-Catena F; Finazzi S; Campolo J; Taioli E; Novembrino C; Colucci P; Accinni R; De Franceschi M; Fasano MA; Maiolo AT
Perit Dial Int; 2000; 20(2):169-73. PubMed ID: 10809239
[TBL] [Abstract][Full Text] [Related]
11. Effect of incremental doses of folate on homocysteine and metabolically related vitamin concentrations in nondiabetic patients on peritoneal dialysis.
de Vecchi AF; Novembrino C; Patrosso MC; Cresseri D; Ippolito S; Rosina M; Colucci P; Lando G; Bamonti Catena F
ASAIO J; 2003; 49(6):655-9. PubMed ID: 14655730
[TBL] [Abstract][Full Text] [Related]
12. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
[TBL] [Abstract][Full Text] [Related]
13. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
Sjöberg B; Anderstam B; Suliman M; Alvestrand A
Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine as a cardiovascular risk factor.
Biasioli S; Schiavon R
Blood Purif; 2000; 18(3):177-82. PubMed ID: 10859420
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.
Bostom AG; Shemin D; Lapane KL; Miller JW; Sutherland P; Nadeau M; Seyoum E; Hartman W; Prior R; Wilson PW
Atherosclerosis; 1995 Apr; 114(1):93-103. PubMed ID: 7605381
[TBL] [Abstract][Full Text] [Related]
16. Study of the homocysteine status in children with chronic renal failure.
Farid FA; Faheem MS; Heshmat NM; Shaheen KY; Saad SS
Am J Nephrol; 2004; 24(3):289-95. PubMed ID: 15087588
[TBL] [Abstract][Full Text] [Related]
17. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.
Buccianti G; Baragetti I; Bamonti F; Furiani S; Dorighet V; Patrosso C
J Nephrol; 2004; 17(3):405-10. PubMed ID: 15365961
[TBL] [Abstract][Full Text] [Related]
18. Influence of vitamin-optimized plasma homocysteine cutoff values on the prevalence of hyperhomocysteinemia in healthy adults.
Fokkema MR; Weijer JM; Dijck-Brouwer DA; van Doormaal JJ; Muskiet FA
Clin Chem; 2001 Jun; 47(6):1001-7. PubMed ID: 11375284
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
20. The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels.
Galli F; Benedetti S; Buoncristiani U; Piroddi M; Conte C; Canestrari F; Buoncristiani E; Floridi A
Kidney Int; 2003 Aug; 64(2):748-55. PubMed ID: 12846775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
